Ophthotech Corporation announced the election of Calvin (Cal) W. Roberts, MD, Senior Vice President and Chief Medical Officer, Eye Care at Bausch Health Companies, and Clinical Professor of Ophthalmology at Weill Medical College of Cornell University, to its Board of Directors, effective as of January 1.
Dr. Roberts brings more than 25 years of experience in the pharma/biotech industry and is well-respected for his business expertise, industry experience and ophthalmic leadership.
“We are excited to welcome Dr. Roberts, a well-known physician and experienced executive in our industry, to our Board of Directors,” Glenn P. Sblendorio, Chief Executive Officer and President of Ophthotech and David R. Guyer, M.D., Executive Chairman of Ophthotech, stated in a company news release.
Mr. Sblendorio added, “The magnitude of relevant ophthalmic expertise and industry experience that Cal brings to Ophthotech is extremely valuable as we continue to develop and advance our pipeline of novel therapeutics and gene therapies for retinal diseases. We believe the addition of Cal to our board is another important step as we focus on creating value for shareholders.”
“As Ophthotech positions itself at the forefront of developing transformative treatments for orphan and age-related retinal diseases, I am excited to join the Board of Ophthotech at this important time,” stated Dr. Roberts. “Forming partnerships between industry and physicians is extremely important to me, and I look forward to working closely with the Board and management team to build on the foundation that Ophthotech has created.”